Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Argent Biopharma ( (AU:RGT) ) has provided an announcement.
Argent Biopharma Limited announced the issuance of 2,252,381 ordinary fully paid securities to creditors as a substitute for cash payments. This strategic move aims to manage financial obligations while maintaining liquidity, potentially impacting the company’s financial stability and stakeholder confidence.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange (ASX) under the issuer code RGT.
Average Trading Volume: 98,425
Technical Sentiment Signal: Sell
Current Market Cap: A$8.68M
Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.